v3.26.1
SEGMENT INFORMATION - Schedule of Segment Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Financial information regarding the Company's reportable segments        
Depreciation and Amortization $ 79,641 $ 69,904 $ 155,366 $ 135,551
Capital Expenditures 57,563 63,425 122,959 120,287
Operating Segment        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 78,537 69,091 153,127 133,876
Capital Expenditures 54,618 61,185 117,452 117,250
Operating Segment | Pharma        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 39,260 34,169 74,903 65,317
Capital Expenditures 27,694 30,124 56,585 59,575
Operating Segment | Beauty        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 24,750 21,475 49,473 41,537
Capital Expenditures 18,774 15,448 38,973 31,590
Operating Segment | Closures        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 14,527 13,447 28,751 27,022
Capital Expenditures 8,150 15,613 21,894 26,085
Corporate & Other        
Financial information regarding the Company's reportable segments        
Depreciation and Amortization 1,104 813 2,239 1,675
Capital Expenditures 3,427 3,135 6,132 6,068
Transfer of Corporate Expenditures        
Financial information regarding the Company's reportable segments        
Capital Expenditures $ (482) $ (895) $ (625) $ (3,031)